{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:01:48Z","timestamp":1749096108726,"version":"3.41.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11154-024-09922-9","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T03:04:53Z","timestamp":1730948693000},"page":"467-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GHRH and the prostate"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2322-8986","authenticated-orcid":false,"given":"Laura","family":"Mu\u00f1oz-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4897-1549","authenticated-orcid":false,"given":"Irene D.","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-4222","authenticated-orcid":false,"given":"Ana M.","family":"Bajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"9922_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/endo-69-2-225","volume":"69","author":"S Reichlin","year":"1961","unstructured":"Reichlin S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology. 1961;69:225\u201330. https:\/\/doi.org\/10.1210\/endo-69-2-225.","journal-title":"Endocrinology"},{"issue":"1","key":"9922_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3181\/00379727-119-30138","volume":"119","author":"AV Schally","year":"1965","unstructured":"Schally AV, Steelman SL, Bowers CY. Effect of hypothalamic extracts on release of growth hormone in vitro. Proc Soc Exp Biol Med. 1965;119(1):208\u201312. https:\/\/doi.org\/10.3181\/00379727-119-30138.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"9922_CR3","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1210\/endo-83-4-783","volume":"83","author":"L Krulich","year":"1968","unstructured":"Krulich L, Dhariwal AP, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology. 1968;83(4):783\u201390. https:\/\/doi.org\/10.1210\/endo-83-4-783.","journal-title":"Endocrinology"},{"key":"9922_CR4","first-page":"259","volume":"74","author":"LA Frohman","year":"1981","unstructured":"Frohman LA, Szabo M. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Prog Clin Biol Res. 1981;74:259\u201371.","journal-title":"Prog Clin Biol Res"},{"issue":"4572","key":"9922_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.6812220","volume":"218","author":"R Guillemin","year":"1982","unstructured":"Guillemin R, Brazeau P, B\u00f6hlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982;218(4572):585\u20137. https:\/\/doi.org\/10.1126\/science.6812220.","journal-title":"Science"},{"issue":"5889","key":"9922_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/300276a0","volume":"300","author":"J Rivier","year":"1982","unstructured":"Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature. 1982;300(5889):276\u20138. https:\/\/doi.org\/10.1038\/300276a0.","journal-title":"Nature"},{"issue":"4","key":"9922_CR7","first-page":"277","volume":"27","author":"LA Frohman","year":"2002","unstructured":"Frohman LA, Kineman RD. Growth hormone-releasing hormone and pituitary somatotrope proliferation. Minerva Endocrinol. 2002;27(4):277\u201385.","journal-title":"Minerva Endocrinol"},{"key":"9922_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0083-6729(05)70001-7","volume":"70","author":"H Kiaris","year":"2005","unstructured":"Kiaris H, Schally AV, Kalofoutis A. Extrapituitary effects of the growth hormone-releasing hormone. Vitam Horm. 2005;70:1\u201324. https:\/\/doi.org\/10.1016\/S0083-6729(05)70001-7.","journal-title":"Vitam Horm"},{"issue":"5","key":"9922_CR9","first-page":"427","volume":"62","author":"LA Frohman","year":"1989","unstructured":"Frohman LA, Downs TR, Chomczynski P, Brar A, Kashio Y. Regulation of growth hormone-releasing hormone gene expression and biosynthesis. Yale J Biol Med. 1989;62(5):427\u201333.","journal-title":"Yale J Biol Med"},{"issue":"14","key":"9922_CR10","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1073\/pnas.81.14.4302","volume":"81","author":"N Ling","year":"1984","unstructured":"Ling N, Esch F, B\u00f6hlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A. 1984;81(14):4302\u20136. https:\/\/doi.org\/10.1073\/pnas.81.14.4302.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"9922_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/ENDO:23:2-3:199","volume":"23","author":"SF Posner","year":"2004","unstructured":"Posner SF, Vaslet CA, Jurofcik M, Lee A, Seidah NG, Nillni EA. Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1. Endocrine. 2004;23(2\u20133):199\u2013213. https:\/\/doi.org\/10.1385\/ENDO:23:2-3:199.","journal-title":"Endocrine"},{"issue":"1","key":"9922_CR12","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1038\/s41467-020-18945-0","volume":"11","author":"F Zhou","year":"2020","unstructured":"Zhou F, Zhang H, Cong Z, Zhao LH, Zhou Q, Mao C, Cheng X, Shen DD, Cai X, Ma C, Wang Y, Dai A, Zhou Y, Sun W, Zhao F, Zhao S, Jiang H, Jiang Y, Yang D, Eric XuH, Zhang Y, Wang MW. Structural basis for activation of the growth hormone-releasing hormone receptor. Nat Commun. 2020;11(1):5205. https:\/\/doi.org\/10.1038\/s41467-020-18945-0.","journal-title":"Nat Commun"},{"key":"9922_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00210616","volume":"93","author":"A Pezzolo","year":"1994","unstructured":"Pezzolo A, Gimelli G, Sposito M, Giussani U, Rossi E, Zuffardi O. Definitive assignment of the growth hormone-releasing factor gene to 20q11.2. Hum Genet. 1994;93:213\u20134. https:\/\/doi.org\/10.1007\/BF00210616.","journal-title":"Hum Genet."},{"key":"9922_CR14","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/mend.15.12.0747","volume":"15","author":"N Mutsuga","year":"2001","unstructured":"Mutsuga N, Iwasaki Y, Morishita M, Nomura A, Yamamori E, Yoshida M, Asai M, Ozaki N, Kambe F, Seo H, Oiso Y, Saito H. Homeobox protein Gsh-1- dependent regulator of the rat GHRH gene promoter. Mol Endocrinol. 2001;15:2149\u201356. https:\/\/doi.org\/10.1210\/mend.15.12.0747.","journal-title":"Mol Endocrinol"},{"key":"9922_CR15","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.4161\/cc.9.20.13787","volume":"9","author":"N Barabutis","year":"2010","unstructured":"Barabutis N, Schally AV. Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology. Cell Cycle. 2010;9:4110\u20136. https:\/\/doi.org\/10.4161\/cc.9.20.13787.","journal-title":"Cell Cycle"},{"key":"9922_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.162.3853.580","volume":"162","author":"LA Frohman","year":"1968","unstructured":"Frohman LA, Nernardis LL, Kant KJ. Hypothalamic stimulation of growth hormone secretion. Science. 1968;162:580\u20132. https:\/\/doi.org\/10.1126\/science.162.3853.580.","journal-title":"Science"},{"issue":"3","key":"9922_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1210\/endo.130.3.1537276","volume":"130","author":"A Bagnato","year":"1992","unstructured":"Bagnato A, Moretti C, Ohnishi J, Frajese G, Catt KJ. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary. Endocrinology. 1992;130(3):1097\u2013102. https:\/\/doi.org\/10.1210\/endo.130.3.1537276.","journal-title":"Endocrinology"},{"issue":"1","key":"9922_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/jcem.75.1.1619020","volume":"75","author":"SA Berry","year":"1992","unstructured":"Berry SA, Srivastava CH, Rubin LR, Phipps WR, Pescovitz OH. Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. J Clin Endocrinol Metab. 1992;75(1):281\u20134. https:\/\/doi.org\/10.1210\/jcem.75.1.1619020.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9922_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/jcp.37.8.931","volume":"37","author":"FT Bosman","year":"1984","unstructured":"Bosman FT, de la Riviere AB, Giard RW, Verhofstad AA, Cramer-Knijnenburg G. Amine and peptide hormone production by lung carcinoid: a clinicopathological and immunocytochemical study. J Clin Pathol. 1984;37(8):931\u20136. https:\/\/doi.org\/10.1136\/jcp.37.8.931.","journal-title":"J Clin Pathol"},{"key":"9922_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0015-0282(00)01658-7","volume":"75","author":"O Khorram","year":"2001","unstructured":"Khorram O, Garthwaite M, Grosen E, Golos T. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril. 2001;75:174\u20139. https:\/\/doi.org\/10.1016\/S0015-0282(00)01658-7.","journal-title":"Fertil Steril"},{"key":"9922_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1043-2760(02)00632-X","volume":"13","author":"C Moretti","year":"2002","unstructured":"Moretti C, Mencacci C, Frajese GV, Cerilli M, Frajese G. Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system. Trends Endocrinol Metab. 2002;13:428\u201335. https:\/\/doi.org\/10.1016\/S1043-2760(02)00632-X.","journal-title":"Trends Endocrinol Metab"},{"key":"9922_CR22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1210\/endo.131.6.1332849","volume":"131","author":"T Ciampani","year":"1992","unstructured":"Ciampani T, Fabbri A, Isidori A, Dufau ML. Growthhormone-releasing hormone is produced by rat Leydigcell in culture and acts as a positive regulator of Leydigcell function. Endocrinology. 1992;131:2785\u201392. https:\/\/doi.org\/10.1210\/endo.131.6.1332849.","journal-title":"Endocrinology"},{"key":"9922_CR23","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1210\/endo.136.9.7649123","volume":"136","author":"S Matsubara","year":"1995","unstructured":"Matsubara S, Sato M, Mizobuchi M, Niimi M, Takahara J. Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRHreceptor in various rat tissues. Endocrinology. 1995;136:4147\u201350. https:\/\/doi.org\/10.1210\/endo.136.9.7649123.","journal-title":"Endocrinology"},{"key":"9922_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1517\/13543784.12.8.1385","volume":"12","author":"H Kiaris","year":"2003","unstructured":"Kiaris H, Koutsilieris M, Kalofoutis A, Schally AV. Growth hormone-releasing hormone and extrapituitary tumorigenesis: therapeutic and diagnostic applica-tions of growth hormone-releasing hormone antagonists. Expert Opin Investig Drugs. 2003;12:1385\u201394. https:\/\/doi.org\/10.1517\/13543784.12.8.1385.","journal-title":"Expert Opin Investig Drugs"},{"key":"9922_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1749-6632.1996.tb17483.x","volume":"805","author":"KE Mayo","year":"1996","unstructured":"Mayo KE, Miller TL, DeAlmeida V, Zheng J, Godfrey PA. The growth-hormone-releasing hormone receptor: signal transduction, gene expression, and physiological function in growth regulation. Ann N Y Acad Sci. 1996;805:184\u2013203. https:\/\/doi.org\/10.1111\/j.1749-6632.1996.tb17483.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"9922_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1210\/jcem-59-2-263","volume":"59","author":"T Shibasaki","year":"1984","unstructured":"Shibasaki T, Kiyosawa Y, Masuda A, Nakahara M, Imaki T, Wakabayashi I, Demura H, Shizume K, Ling N. Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab. 1984;59(2):263\u20138. https:\/\/doi.org\/10.1210\/jcem-59-2-263.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9922_CR27","first-page":"628","volume":"53","author":"A Stephanou","year":"1991","unstructured":"Stephanou A, Knight RA, Lightman SL. Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. Neuroendocrinology. 1991;53(6):628\u201333.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"9922_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2010.05.022","volume":"298","author":"HM Wu","year":"2010","unstructured":"Wu HM, Schally AV, Cheng JC, Zarandi M, Varga J, Leung PC. Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKC\u03b4-mediated activation of p53\/p21. Cancer Lett. 2010;298(1):16\u201325. https:\/\/doi.org\/10.1016\/j.canlet.2010.05.022.","journal-title":"Cancer Lett"},{"issue":"5","key":"9922_CR29","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3892\/ijo_00000613","volume":"36","author":"N Barabutis","year":"2010","unstructured":"Barabutis N, Siejka A, Schally AV. Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines. Int J Oncol. 2010;36(5):1285\u20139. https:\/\/doi.org\/10.3892\/ijo_00000613.","journal-title":"Int J Oncol"},{"key":"9922_CR30","doi-asserted-by":"publisher","first-page":"17424","DOI":"10.1073\/pnas.0506844102","volume":"102","author":"A Havt","year":"2005","unstructured":"Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, K\u00f6ster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA. 2005;102:17424\u20139. https:\/\/doi.org\/10.1073\/pnas.0506844102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9922_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/sj.neo.7900074","volume":"2","author":"H Kiaris","year":"2000","unstructured":"Kiaris H, Schally AV, Varga JL. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice. Neoplasia. 2000;2(3):242\u201350. https:\/\/doi.org\/10.1038\/sj.neo.7900074.","journal-title":"Neoplasia"},{"issue":"37","key":"9922_CR32","doi-asserted-by":"publisher","first-page":"15879","DOI":"10.1016\/j.canlet.2010.05.022","volume":"106","author":"CG Ziegler","year":"2009","unstructured":"Ziegler CG, Brown JW, Schally AV, Erler A, Gebauer L, Treszl A, Young L, Fishman LM, Engel JB, Willenberg HS, Petersenn S, Eisenhofer G, Ehrhart-Bornstein M, Bornstein SR. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues. Proc Natl Acad Sci U S A. 2009;106(37):15879\u201384. https:\/\/doi.org\/10.1016\/j.canlet.2010.05.022.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7\u20138","key":"9922_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2119\/molmed.2008.00132","volume":"15","author":"E Theophanous","year":"2009","unstructured":"Theophanous E, Petraki C, Scorilas A, Komborozos V, Veloudis G, Varga JL, Zarandi M, Schally AV, Koutsilieris M. The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer. Mol Med. 2009;15(7\u20138):242\u20137. https:\/\/doi.org\/10.2119\/molmed.2008.00132.","journal-title":"Mol Med"},{"key":"9922_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.636403","volume":"12","author":"J Devesa","year":"2021","unstructured":"Devesa J. The Complex world of regulation of pituitary growth hormone secretion: the role of ghrelin, klotho, and nesfatins in it. Front Endocrinol (Lausanne). 2021;12: 636403. https:\/\/doi.org\/10.3389\/fendo.2021.636403.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9922_CR35","unstructured":"Olarescu NC, Gunawardane K, Hansen TK, et al. Normal physiology of growth hormone in adults. 2019 Oct 16. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferr\u00e8re B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000\u2013. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk279056\/."},{"key":"9922_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.614981","volume":"11","author":"EJ V\u00e9lez","year":"2021","unstructured":"V\u00e9lez EJ, Unniappan S. A comparative update on the neuroendocrine regulation of growth hormone in vertebrates. Front Endocrinol. 2021;11: 614981. https:\/\/doi.org\/10.3389\/fendo.2020.614981.","journal-title":"Front Endocrinol"},{"issue":"7","key":"9922_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40618-016-0440-x","volume":"39","author":"R Granata","year":"2016","unstructured":"Granata R. Peripheral activities of growth hormone-releasing hormone. J Endocrinol Invest. 2016;39(7):721\u20137. https:\/\/doi.org\/10.1007\/s40618-016-0440-x.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"9922_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6.","journal-title":"Signal Transduct Target Ther"},{"key":"9922_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"A Hauser","year":"2017","unstructured":"Hauser A, Attwood M, Rask-Andersen M, Schi\u00f6th HB, Gloriam DE. Trends in GPCR drugdiscovery: new agents, targets and indications. Nat Rev DrugDiscov. 2017;16:829\u201342. https:\/\/doi.org\/10.1038\/nrd.2017.178.","journal-title":"Nat Rev DrugDiscov"},{"issue":"4","key":"9922_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom MC, Schi\u00f6th HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7(4):339\u201357. https:\/\/doi.org\/10.1038\/nrd2518.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9922_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","volume":"17","author":"EJ Whalen","year":"2011","unstructured":"Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists. Trends Mol Med. 2011;17(3):126\u201339. https:\/\/doi.org\/10.1016\/j.molmed.2010.11.004.","journal-title":"Trends Mol Med"},{"issue":"1","key":"9922_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1124\/jpet.108.141531","volume":"328","author":"SS Ericksen","year":"2009","unstructured":"Ericksen SS, Cummings DF, Weinstein H, Schetz JA. Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding. J Pharmacol Exp Ther. 2009;328(1):40\u201354. https:\/\/doi.org\/10.1124\/jpet.108.141531.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9922_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mce.2010.07.009","volume":"331","author":"NJ Smith","year":"2011","unstructured":"Smith NJ, Bennett KA, Milligan G. When simple agonism is not enough: emerging modalities of GPCR ligands. Mol Cell Endocrinol. 2011;331(2):241\u20137. https:\/\/doi.org\/10.1016\/j.mce.2010.07.009.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"9922_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","volume":"6","author":"D Yang","year":"2021","unstructured":"Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, Yuliantie E, Xie L, Tao H, Cheng J, Liu Q, Zhao S, Shui W, Jiang Y, Wang MW. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021;6(1):7. https:\/\/doi.org\/10.1038\/s41392-020-00435-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"9922_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrd3320","volume":"10","author":"R Lappano","year":"2011","unstructured":"Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011;10(1):47\u201360. https:\/\/doi.org\/10.1038\/nrd3320.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9922_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/mend.7.1.7680413","volume":"7","author":"BD Gaylinn","year":"1993","unstructured":"Gaylinn BD, Harrison JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol. 1993;7(1):77\u201384. https:\/\/doi.org\/10.1210\/mend.7.1.7680413.","journal-title":"Mol Endocrinol"},{"key":"9922_CR47","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","volume":"63","author":"R Fredriksson","year":"2003","unstructured":"Fredriksson R, Lagerstrom MC, Lundin LG, Schi\u00f6th HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63:1256\u201372. https:\/\/doi.org\/10.1124\/mol.63.6.1256.","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"9922_CR48","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1124\/mol.104.009001","volume":"67","author":"R Fredriksson","year":"2005","unstructured":"Fredriksson R, Schi\u00f6th HB. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol. 2005;67(5):1414\u201325. https:\/\/doi.org\/10.1124\/mol.104.009001.","journal-title":"Mol Pharmacol"},{"key":"9922_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/protein\/7.2.195","volume":"7","author":"TK Attwood","year":"1994","unstructured":"Attwood TK, Findlay JB. Fingerprinting G-protein-coupled receptors. Protein Eng. 1994;7:195\u2013203. https:\/\/doi.org\/10.1093\/protein\/7.2.195.","journal-title":"Protein Eng"},{"issue":"18","key":"9922_CR50","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1073\/pnas.1000640107","volume":"107","author":"A Maeda","year":"2010","unstructured":"Maeda A, Okano K, Park PS, Lem J, Crouch RK, Maeda T, Palczewski K. Palmitoylation stabilizes unliganded rodopsin. Proc Natl Acad Sci U S A. 2010;107(18):8428\u201333. https:\/\/doi.org\/10.1073\/pnas.1000640107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"9922_CR51","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1038\/sj.bjp.0707662","volume":"153","author":"AB Tobin","year":"2008","unstructured":"Tobin AB. G-protein-coupled receptor phosphorylation: where, when and by whom. Br J Pharmacol. 2008;153(Suppl 1):S167\u201376. https:\/\/doi.org\/10.1038\/sj.bjp.0707662.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9922_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tips.2011.09.003","volume":"33","author":"V Katritch","year":"2012","unstructured":"Katritch V, Cherezov V, Stevens RC. Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci. 2012;33(1):17\u201327. https:\/\/doi.org\/10.1016\/j.tips.2011.09.003.","journal-title":"Trends Pharmacol Sci"},{"key":"9922_CR53","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1073\/pnas.180313297","volume":"97","author":"Z Rekasi","year":"2000","unstructured":"Rekasi Z, Czompoly T, Schally AV, Halmos G. Isolation and sequencing of cDNAs for splice variants of growth hormone releasing hormone receptors from human cancers. Proc Natl Acad Sci USA. 2000;97:10561\u20136. https:\/\/doi.org\/10.1073\/pnas.180313297.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9922_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1006\/geno.1994.1185","volume":"20","author":"NC Vamvakopoulos","year":"1994","unstructured":"Vamvakopoulos NC, Kunz J, Olberding U, Scherer SW, Sioutopoulou TO, Schneider V, Durkin AS, Nierman WC. Mapping the human growth hormone releasing hormone receptor [GHRHR] gene to the short arm of chromosome 7 [7p13-p21] near the epidermal growth factor receptor [EGFR]. Genomics. 1994;20:338\u201340. https:\/\/doi.org\/10.1006\/geno.1994.1185.","journal-title":"Genomics"},{"issue":"8","key":"9922_CR55","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1210\/jcem.80.8.7629234","volume":"80","author":"J Tang","year":"1995","unstructured":"Tang J, Lagac\u00e9 G, Castagn\u00e9 J, Collu R. Identification of human growth hormone-releasing hormone receptor splicing variants. J Clin Endocrinol Metab. 1995;80(8):2381\u20137. https:\/\/doi.org\/10.1210\/jcem.80.8.7629234.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9922_CR56","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1210\/jc.2002-020347","volume":"87","author":"G Halmos","year":"2002","unstructured":"Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL, Rekasi Z. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. J Clin Endocrinol Metab. 2002;87(10):4707\u201314. https:\/\/doi.org\/10.1210\/jc.2002-020347.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9922_CR57","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3892\/ijo.2011.1098","volume":"39","author":"E Pozsgai","year":"2011","unstructured":"Pozsgai E, Schally AV, Hocsak E, Zarandi M, Rick F, Bellyei S. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines. Int J Oncol. 2011;39(4):1025\u201332. https:\/\/doi.org\/10.3892\/ijo.2011.1098.","journal-title":"Int J Oncol"},{"issue":"1","key":"9922_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ncpendmet0677","volume":"4","author":"AV Schally","year":"2008","unstructured":"Schally AV, Varga JL, Engel JB. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab. 2008;4(1):33\u201343. https:\/\/doi.org\/10.1038\/ncpendmet0677.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"47","key":"9922_CR59","doi-asserted-by":"publisher","first-page":"12028","DOI":"10.1073\/pnas.1813375115","volume":"115","author":"AV Schally","year":"2018","unstructured":"Schally AV, Wang H, He J, Cai R, Sha W, Popovics P, Perez R, Vidaurre I, Zhang X. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proc Natl Acad Sci U S A. 2018;115(47):12028\u201333. https:\/\/doi.org\/10.1073\/pnas.1813375115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9922_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092671","volume":"27","author":"Z Szabo","year":"2022","unstructured":"Szabo Z, Juhasz E, Schally AV, Dezso B, Huga S, Hernadi Z, Halmos G, Kiss C. Expression of growth hormone-releasing hormone and its receptor splice variants in primary human endometrial carcinomas: novel therapeutic approaches. Molecules. 2022;27(9): 2671. https:\/\/doi.org\/10.3390\/molecules27092671.","journal-title":"Molecules"},{"issue":"2","key":"9922_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/pros.1125","volume":"49","author":"LK Chopin","year":"2001","unstructured":"Chopin LK, Herington AC. A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines. Prostate. 2001;49(2):116\u201321. https:\/\/doi.org\/10.1002\/pros.1125.","journal-title":"Prostate"},{"issue":"3","key":"9922_CR62","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1073\/pnas.1323102111","volume":"111","author":"CD Fahrenholtz","year":"2014","unstructured":"Fahrenholtz CD, Rick FG, Garcia MI, Zarandi M, Cai RZ, Block NL, Schally AV, Burnstein KL. Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer. Proc Natl Acad Sci USA. 2014;111(3):1084\u20139. https:\/\/doi.org\/10.1073\/pnas.1323102111.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"9922_CR63","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S0196-9781(02)00043-8","volume":"23","author":"A Plonowski","year":"2002","unstructured":"Plonowski A, Schally AV, Busto R, Krupa M, Varga JL, Halmos G. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Peptides. 2002;23(6):1127\u201333. https:\/\/doi.org\/10.1016\/S0196-9781(02)00043-8.","journal-title":"Peptides"},{"key":"9922_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.regpep.2007.12.008","volume":"147","author":"I Chatzistamou","year":"2008","unstructured":"Chatzistamou I, Volakaki AA, Schally AV, Kiaris H, Kittas C. Expression of growth hormone\u2013releasing hormone receptor splice variant 1 in primary human melanomas. Regul Pept. 2008;147:33\u20136. https:\/\/doi.org\/10.1016\/j.regpep.2007.12.008.","journal-title":"Regul Pept"},{"issue":"Pt B","key":"9922_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejphar.2015.05.016","volume":"763","author":"NM Duc","year":"2015","unstructured":"Duc NM, Kim HR, Chung KY. Structural mechanism of G protein activation by G protein- coupled receptor. Eur J Pharmacol. 2015;763(Pt B):214\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.016.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9922_CR66","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/s41467-020-18500-x","volume":"11","author":"D Abboud","year":"2020","unstructured":"Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevign\u00e9 A, Ectors F, Plenevaux A, Pirotte B, Beckers A, Hanson J. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq\/11. Nat Commun. 2020;11(1):4752. https:\/\/doi.org\/10.1038\/s41467-020-18500-x.","journal-title":"Nat Commun"},{"issue":"12","key":"9922_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102618","volume":"298","author":"D Kankanamge","year":"2022","unstructured":"Kankanamge D, Tennakoon M, Karunarathne A, Gautam N. G protein gamma subunit, a hidden master regulator of GPCR signaling. J Biol Chem. 2022;298(12): 102618. https:\/\/doi.org\/10.1016\/j.jbc.2022.102618.","journal-title":"J Biol Chem"},{"key":"9922_CR68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4236\/oju.2020.106023","volume":"10","author":"J Bindzi","year":"2020","unstructured":"Bindzi J, Yang Y, Yan X, Zhong Y, Tian Y. Growth Hormone Releasing Hormone Receptors Antagonists and Cancers: Do GHRH-R Antagonists Play a Role in the Management of Prostate Cancer? Open J Urology. 2020;10:201\u201310. https:\/\/doi.org\/10.4236\/oju.2020.106023.","journal-title":"Open J Urology"},{"issue":"1","key":"9922_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-024-01524-x","volume":"17","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu Y, Liu J, Chen J, Wang J, Hua H, Jiang Y. cAMP-PKA\/EPAC signaling and cancer: the interplay in tumor microenvironment. J Hematol Oncol. 2024;17(1):5. https:\/\/doi.org\/10.1186\/s13045-024-01524-x.","journal-title":"J Hematol Oncol"},{"key":"9922_CR70","doi-asserted-by":"publisher","unstructured":"Bonert VS, Melmed S. Growth Hormone. In: Melmed S, editor. The Pituitary (Fourth Edition), Academic Press; 2017. pp 85\u2013127. https:\/\/doi.org\/10.1016\/B978-0-12-804169-7.00004-0.","DOI":"10.1016\/B978-0-12-804169-7.00004-0"},{"issue":"46","key":"9922_CR71","doi-asserted-by":"publisher","first-page":"16880","DOI":"10.1073\/pnas.0508202102","volume":"102","author":"X Bonnefont","year":"2005","unstructured":"Bonnefont X, Lacampagne A, Sanchez-Hormigo A, Fino E, Creff A, Mathieu MN, Smallwood S, Carmignac D, Fontanaud P, Travo P, Alonso G, Courtois-Coutry N, Pincus SM, Robinson IC, Mollard P. Revealing the large-scale network organization of growth hormone-secreting cells. Proc Natl Acad Sci USA. 2005;102(46):16880\u20135. https:\/\/doi.org\/10.1073\/pnas.0508202102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9922_CR72","doi-asserted-by":"publisher","first-page":"16686","DOI":"10.1038\/s41598-020-73840-4","volume":"10","author":"EJ V\u00e9lez","year":"2020","unstructured":"V\u00e9lez EJ, Unniappan S. Nesfatin-1 and nesfatin-1-like peptide suppress growth hormone synthesis via the AC\/PKA\/CREB pathway in mammalian somatotrophs. Sci Rep. 2020;10(1):16686. https:\/\/doi.org\/10.1038\/s41598-020-73840-4.","journal-title":"Sci Rep"},{"issue":"2","key":"9922_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1385\/ENDO:12:2:99","volume":"12","author":"LE Cohen","year":"2000","unstructured":"Cohen LE. Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine. 2000;12(2):99\u2013106. https:\/\/doi.org\/10.1385\/ENDO:12:2:99.","journal-title":"Endocrine"},{"issue":"1","key":"9922_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/EJE-13-0733","volume":"170","author":"C Norman","year":"2014","unstructured":"Norman C, Rollene NL, Erickson D, Miles JM, Bowers CY, Veldhuis JD. Estradiol regulates GH-releasing peptide\u2019s interactions with GH-releasing hormone and somatostatin in postmenopausal women. Eur J Endocrinol. 2014;170(1):121\u20139. https:\/\/doi.org\/10.1530\/EJE-13-0733.","journal-title":"Eur J Endocrinol"},{"key":"9922_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.tem.2011.03.006","volume":"22","author":"H Kiaris","year":"2011","unstructured":"Kiaris H, Chatzistamou I, Papavassiliou AG, Schally AV. Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol Metab. 2011;22:311\u20137. https:\/\/doi.org\/10.1016\/j.tem.2011.03.006.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"9922_CR76","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1073\/pnas.1120588109","volume":"109","author":"FG Rick","year":"2012","unstructured":"Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S. Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases. Proc Natl Acad Sci USA. 2012;109(5):1655\u201360. https:\/\/doi.org\/10.1073\/pnas.1120588109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9922_CR77","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1210\/endo.141.6.7513","volume":"141","author":"CM Pombo","year":"2000","unstructured":"Pombo CM, Zalvide J, Gaylinn BD, Di\u00e9guez C. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology. 2000;141:2113\u20139. https:\/\/doi.org\/10.1210\/endo.141.6.7513.","journal-title":"Endocrinology"},{"key":"9922_CR78","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1210\/me.2005-0001","volume":"20","author":"G Siriwardana","year":"2006","unstructured":"Siriwardana G, Bradford A, Coy D, Zeitler P. Autocrine\/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol. 2006;20:2010\u20139. https:\/\/doi.org\/10.1210\/me.2005-0001.","journal-title":"Mol Endocrinol"},{"key":"9922_CR79","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1385\/ENDO:12:3:257","volume":"12","author":"P Zeitler","year":"2000","unstructured":"Zeitler P, Siriwardana G. Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone. Endocrine. 2000;12:257\u201364. https:\/\/doi.org\/10.1385\/ENDO:12:3:257.","journal-title":"Endocrine"},{"key":"9922_CR80","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","volume":"59","author":"AS Alzahrani","year":"2019","unstructured":"Alzahrani AS. PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019;59:125\u201332. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.009.","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"9922_CR81","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.bbrc.2003.09.132","volume":"310","author":"N Gao","year":"2003","unstructured":"Gao N, Zhang Z, Jiang BH, Shi X. Role of PI3K\/AKT\/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun. 2003;310(4):1124\u201332. https:\/\/doi.org\/10.1016\/j.bbrc.2003.09.132.","journal-title":"Biochem Biophys Res Commun"},{"key":"9922_CR82","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/JIR.S353489","volume":"15","author":"T Mengie Ayele","year":"2022","unstructured":"Mengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale Kassie A, Chekol AE. Role of JAK2\/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: a systemic review. J Inflamm Res. 2022;15:1349\u201364. https:\/\/doi.org\/10.2147\/JIR.S353489.","journal-title":"J Inflamm Res"},{"issue":"10","key":"9922_CR83","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/pros.21142","volume":"70","author":"A Siejka","year":"2010","unstructured":"Siejka A, Schally AV, Block NL, Barabutis N. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells. Prostate. 2010;70(10):1087\u201393. https:\/\/doi.org\/10.1002\/pros.21142.","journal-title":"Prostate"},{"issue":"6","key":"9922_CR84","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2353\/ajpath.2008.071054","volume":"172","author":"J Abdulghani","year":"2008","unstructured":"Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Nevalainen MT. Stat3 promotes metastatic progression of prostate cancer. Am J Pathol. 2008;172(6):1717\u201328. https:\/\/doi.org\/10.2353\/ajpath.2008.071054.","journal-title":"Am J Pathol"},{"key":"9922_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.ircmb.2018.02.008","volume":"339","author":"K Senarath","year":"2018","unstructured":"Senarath K, Kankanamge D, Samaradivakara S, Ratnayake K, Tennakoon M, Karunarathne A. Regulation of G Protein \u03b2\u03b3 Signaling. Int Rev Cell Mol Biol. 2018;339:133\u201391. https:\/\/doi.org\/10.1016\/bs.ircmb.2018.02.008.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"12","key":"9922_CR86","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.tips.2007.09.007","volume":"28","author":"N Delcourt","year":"2007","unstructured":"Delcourt N, Bockaert J, Marin P. GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol Sci. 2007;28(12):602\u20137. https:\/\/doi.org\/10.1016\/j.tips.2007.09.007.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"9922_CR87","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.tips.2011.04.002","volume":"32","author":"NJ Pyne","year":"2011","unstructured":"Pyne NJ, Pyne S. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow? Trends Pharmacol Sci. 2011;32(8):443\u201350. https:\/\/doi.org\/10.1016\/j.tips.2011.04.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"21","key":"9922_CR88","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1111\/febs.12509","volume":"280","author":"AJ George","year":"2013","unstructured":"George AJ, Hannan RD, Thomas WG. Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approaches. FEBS J. 2013;280(21):5258\u201368. https:\/\/doi.org\/10.1111\/febs.12509.","journal-title":"FEBS J"},{"issue":"2","key":"9922_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/1570161112666140226123745","volume":"12","author":"S Sur","year":"2014","unstructured":"Sur S, Agrawal DK. Transactivation of EGFR by G protein-coupled receptor in the pathophysiology of intimal hyperplasia. Curr Vasc Pharmacol. 2014;12(2):190\u2013201. https:\/\/doi.org\/10.2174\/1570161112666140226123745.","journal-title":"Curr Vasc Pharmacol"},{"key":"9922_CR90","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coemr.2020.10.003","volume":"16","author":"LE Kilpatrick","year":"2021","unstructured":"Kilpatrick LE, Hill SJ. Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. Curr Opin Endocr Metab Res. 2021;16:102\u201312. https:\/\/doi.org\/10.1016\/j.coemr.2020.10.003.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"9922_CR91","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10637-014-0131-4","volume":"32","author":"L Mu\u00f1oz-Moreno","year":"2014","unstructured":"Mu\u00f1oz-Moreno L, Arenas MI, Carmena MJ, Schally AV, Prieto JC. Bajo AM Growth Hormone-Releasing Hormone Antagonists Abolish the Transactivation of Human Epidermal Growth Factor Receptors in Advanced Prostate Cancer Models. Invest New Drugs. 2014;32:871\u201382. https:\/\/doi.org\/10.1007\/s10637-014-0131-4.","journal-title":"Invest New Drugs"},{"key":"9922_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2017.02.011","volume":"446","author":"L Mu\u00f1oz-Moreno","year":"2017","unstructured":"Mu\u00f1oz-Moreno L, Bajo AM, Prieto JC, Carmena MJ. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR\/HER2 transactivation in prostate cancer cells. Mol Cell Endocrinol. 2017;446:59\u201369. https:\/\/doi.org\/10.1016\/j.mce.2017.02.011.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"9922_CR93","first-page":"3438","volume":"8","author":"G Di Lorenzo","year":"2002","unstructured":"Di Lorenzo G, Tortora G, D\u2019Armiento FP, De Rosa G, Staibano S, Autorino R, D\u2019Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res. 2002;8(11):3438\u201344.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"9922_CR94","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1158\/0008-5472.CAN-05-3928","volume":"66","author":"R Berger","year":"2006","unstructured":"Berger R, Lin DI, Nieto M, Sicinska E, Garraway LA, Adams H, Signoretti S, Hahn WC, Loda M. Androgen-dependent regulation of Her-2\/neu in prostate cancer cells. Cancer Res. 2006;66(11):5723\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3928.","journal-title":"Cancer Res"},{"key":"9922_CR95","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1073\/pnas.1533185100","volume":"100","author":"H Kiaris","year":"2003","unstructured":"Kiaris H, Chatzistamou I, Schally AV, Halmos G, Varga JL, Koutselini H, Kalofoutis A. Ligand- dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci USA. 2003;100:9512\u20137. https:\/\/doi.org\/10.1073\/pnas.1533185100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"40","key":"9922_CR96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106606118","volume":"118","author":"Z Cong","year":"2021","unstructured":"Cong Z, Zhou F, Zhang C, Zou X, Zhang H, Wang Y, Zhou Q, Cai X, Liu Q, Li J, Shao L, Mao C, Wang X, Wu J, Xia T, Zhao LH, Jiang H, Zhang Y, Xu HE, Cheng X, Yang D, Wang MW. Constitutive signal bias mediated by the human GHRHR splice variant 1. Proc Natl Acad Sci USA. 2021;118(40): e2106606118. https:\/\/doi.org\/10.1073\/pnas.2106606118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9922_CR97","unstructured":"Singh O, Bolla SR. Anatomy, Abdomen and Pelvis, Prostate. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024."},{"issue":"26","key":"9922_CR98","doi-asserted-by":"publisher","first-page":"dev200394","DOI":"10.1242\/dev.200394","volume":"149","author":"A Pletcher","year":"2022","unstructured":"Pletcher A, Shibata M. Prostate organogenesis. Development. 2022;149(12):dev200394. https:\/\/doi.org\/10.1242\/dev.200394.","journal-title":"Development"},{"key":"9922_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.vh.2023.06.004","volume":"123","author":"G Halmos","year":"2023","unstructured":"Halmos G, Szabo Z, Juhasz E, Schally AV. Signaling mechanism of growth hormone-releasing hormone receptor. Vitam Horm. 2023;123:1\u201326. https:\/\/doi.org\/10.1016\/bs.vh.2023.06.004.","journal-title":"Vitam Horm"},{"key":"9922_CR100","doi-asserted-by":"publisher","unstructured":"Rick FG, Schally AV, Block NL, Nadji M, Szepeshazi K, Zarandi M, Vidaurre I, Perez R, Halmos G, Szalontay L. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc Natl Acad Sci U S A. 2011;108(9):3755\u201360. https:\/\/doi.org\/10.1073\/pnas.1018086108.","DOI":"10.1073\/pnas.1018086108"},{"issue":"13","key":"9922_CR101","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/pros.23655","volume":"78","author":"P Popovics","year":"2018","unstructured":"Popovics P, Cai R, Sha W, Rick FG, Schally AV. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis. Prostate. 2018;78(13):970\u201380. https:\/\/doi.org\/10.1002\/pros.23655.","journal-title":"Prostate"},{"issue":"2","key":"9922_CR102","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac209","volume":"164","author":"N Barabutis","year":"2022","unstructured":"Barabutis N, Akhter MS, Kubra KT, Jackson K. Growth hormone-releasing hormone in endothelial inflammation. Endocrinology. 2022;164(2): 209. https:\/\/doi.org\/10.1210\/endocr\/bqac209.","journal-title":"Endocrinology"},{"issue":"Pt 3","key":"9922_CR103","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.semcancer.2022.02.017","volume":"86","author":"M Mughees","year":"2022","unstructured":"Mughees M, Kaushal JB, Sharma G, Wajid S, Batra SK, Siddiqui JA. Chemokines and cytokines: axis and allies in prostate cancer pathogenesis. Semin Cancer Biol. 2022;86(Pt 3):497\u2013512. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.017.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"9922_CR104","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/pros.23648","volume":"78","author":"L Mu\u00f1oz-Moreno","year":"2018","unstructured":"Mu\u00f1oz-Moreno L, Schally AV, Prieto JC, Carmena MJ, Bajo AM. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer. Prostate. 2018;78(12):915\u201326. https:\/\/doi.org\/10.1002\/pros.23648.","journal-title":"Prostate"},{"issue":"8","key":"9922_CR105","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/pros.24339","volume":"82","author":"L Mu\u00f1oz-Moreno","year":"2022","unstructured":"Mu\u00f1oz-Moreno L, Carmena MJ, Prieto JC, Schally AV, Bajo AM. Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH). Prostate. 2022;82(8):933\u201341. https:\/\/doi.org\/10.1002\/pros.24339.","journal-title":"Prostate"},{"issue":"3","key":"9922_CR106","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10637-019-00831-2","volume":"38","author":"L Mu\u00f1oz-Moreno","year":"2020","unstructured":"Mu\u00f1oz-Moreno L, Carmena MJ, Schally AV, Prieto JC, Bajo AM. Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists. Invest New Drugs. 2020;38(3):746\u201354. https:\/\/doi.org\/10.1007\/s10637-019-00831-2.","journal-title":"Invest New Drugs"},{"key":"9922_CR107","doi-asserted-by":"publisher","unstructured":"Recouvreux MV, Wu JB, Gao AC, Zonis S, Chesnokova V, Bhowmick N, Chung LW, Melmed S. Androgen receptor regulation of local growth hormone in prostate cancer cells. Endocrinology. 2017;158(7):2255-68. https:\/\/doi.org\/10.1210\/en.2016-19.","DOI":"10.1210\/en.2016-19"},{"issue":"5","key":"9922_CR108","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1210\/endo-117-5-1759","volume":"117","author":"P Robberecht","year":"1985","unstructured":"Robberecht P, Coy DH, Waelbroeck M, Heiman ML, de Neef P, Camus JC, Christophe J. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1\u201329)-NH2 as a GRF antagonist on membranes. Endocrinology. 1985;117(5):1759\u201364. https:\/\/doi.org\/10.1210\/endo-117-5-1759.","journal-title":"Endocrinology"},{"issue":"25","key":"9922_CR109","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.1073\/pnas.91.25.12298","volume":"91","author":"M Zarandi","year":"1994","unstructured":"Zarandi M, Horvath JE, Halmos G, Pinski J, Nagy A, Groot K, Rekasi Z, Schally AV. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 1994;91(25):12298\u2013302. https:\/\/doi.org\/10.1073\/pnas.91.25.12298.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9922_CR110","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1073\/pnas.96.2.692","volume":"96","author":"JL Varga","year":"1999","unstructured":"Varga JL, Schally AV, Csernus VJ, Zar\u00e1ndi M, Halmos G, Groot K, R\u00e9k\u00e1si Z. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc Natl Acad Sci U S A. 1999;96(2):692\u20137. https:\/\/doi.org\/10.1073\/pnas.96.2.692.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9922_CR111","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1073\/pnas.0610860104","volume":"104","author":"S Buchholz","year":"2007","unstructured":"Buchholz S, Schally AV, Engel JB, Hohla F, Heinrich E, Koester F, Varga JL, Halmos G. Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc Natl Acad Sci USA. 2007;104(6):1943\u20136. https:\/\/doi.org\/10.1073\/pnas.0610860104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9922_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170716","volume":"150","author":"R Cai","year":"2022","unstructured":"Cai R, Zhang X, Wang H, Cui T, Halmos G, Sha W, He J, Popovics P, Vidaurre I, Zhang C, Mirsaeidi M, Schally AV. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides. 2022;150: 170716. https:\/\/doi.org\/10.1016\/j.peptides.2021.170716.","journal-title":"Peptides"},{"issue":"5","key":"9922_CR113","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-2008-1073142","volume":"40","author":"AV Schally","year":"2008","unstructured":"Schally AV. New approaches to the therapy of various tumors based on peptide analogues. Horm Metab Res. 2008;40(5):315\u201322. https:\/\/doi.org\/10.1055\/s-2008-1073142.","journal-title":"Horm Metab Res"},{"key":"9922_CR114","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2017.01.009","volume":"89","author":"M Zarandi","year":"2017","unstructured":"Zarandi M, Cai R, Kovacs M, Popovics P, Szalontay L, Cui T, Sha W, Jaszberenyi M, Varga J, Zhang X, Block NL, Rick FG, Halmos G, Schally AV. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Peptides. 2017;89:60\u201370. https:\/\/doi.org\/10.1016\/j.peptides.2017.01.009.","journal-title":"Peptides"},{"issue":"23","key":"9922_CR115","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/jnci\/87.23.1787","volume":"87","author":"J Pinski","year":"1995","unstructured":"Pinski J, Schally AV, Groot K, Halmos G, Szepeshazi K, Zarandi M, Armatis P. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst. 1995;87(23):1787\u201394. https:\/\/doi.org\/10.1093\/jnci\/87.23.1787.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9922_CR116","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3892\/ijo.9.6.1099","volume":"9","author":"J Pinski","year":"1996","unstructured":"Pinski J, Schally A, Jungwirth A, Groot K, Halmos G, Armatis P, Zarandi M, Vadillobuenfil M. Inhibition of growth of human small cell and non-small cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH). Int J Oncol. 1996;9(6):1099\u2013105. https:\/\/doi.org\/10.3892\/ijo.9.6.1099.","journal-title":"Int J Oncol"},{"issue":"3","key":"9922_CR117","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/138620706776055449","volume":"9","author":"AV Schally","year":"2006","unstructured":"Schally AV, Varga JL. Antagonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen. 2006;9(3):163\u201370. https:\/\/doi.org\/10.2174\/138620706776055449.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"6","key":"9922_CR118","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1210\/jc.2004-2179","volume":"90","author":"JB Engel","year":"2005","unstructured":"Engel JB, Keller G, Schally AV, Toller GL, Groot K, Havt A, Armatis P, Zarandi M, Varga JL, Halmos G. Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone. J Clin Endocrinol Metab. 2005;90(6):3614\u201321. https:\/\/doi.org\/10.1210\/jc.2004-2179.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9922_CR119","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1054\/bjoc.2000.1223","volume":"82","author":"K Szepeshazi","year":"2000","unstructured":"Szepeshazi K, Schally AV, Groot K, Armatis P, Halmos G, Herbert F, Szende B, Varga JL, Zarandi M. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br J Cancer. 2000;82(10):1724\u201331. https:\/\/doi.org\/10.1054\/bjoc.2000.1223.","journal-title":"Br J Cancer"},{"issue":"26","key":"9922_CR120","doi-asserted-by":"publisher","first-page":"14894","DOI":"10.1073\/pnas.96.26.14894","volume":"96","author":"H Kiaris","year":"1999","unstructured":"Kiaris H, Schally AV, Varga JL, Groot K, Armatis P. Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. Proc Natl Acad Sci USA. 1999;96(26):14894\u20138. https:\/\/doi.org\/10.1073\/pnas.96.26.14894.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9922_CR121","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/cncr.10865","volume":"95","author":"R Braczkowski","year":"2002","unstructured":"Braczkowski R, Schally AV, Plonowski A, Varga JL, Groot K, Krupa M, Armatis P. Inhibition of proliferation in human MNNG\/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Cancer. 2002;95(8):1735\u201345. https:\/\/doi.org\/10.1002\/cncr.10865.","journal-title":"Cancer"},{"issue":"1","key":"9922_CR122","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1073\/pnas.96.1.226","volume":"96","author":"H Kiaris","year":"1999","unstructured":"Kiaris H, Schally AV. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci USA. 1999;96(1):226\u201331. https:\/\/doi.org\/10.1073\/pnas.96.1.226.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"30","key":"9922_CR123","doi-asserted-by":"publisher","first-page":"10628","DOI":"10.1073\/pnas.0504102102","volume":"102","author":"G Keller","year":"2005","unstructured":"Keller G, Schally AV, Groot K, Toller GL, Havt A, K\u00f6ster F, Armatis P, Halmos G, Zarandi M, Varga JL, Engel JB. Effective treatment of experimental human non-Hodgkin\u2019s lymphomas with antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A. 2005;102(30):10628\u201333. https:\/\/doi.org\/10.1073\/pnas.0504102102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"9922_CR124","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.4161\/cc.8.19.9698","volume":"8","author":"F Hohla","year":"2009","unstructured":"Hohla F, Buchholz S, Schally AV, Seitz S, Rick FG, Szalontay L, Varga JL, Zarandi M, Halmos G, Vidaurre I, Krishan A, Kurtoglu M, Chandna S, Aigner E, Datz C. GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cell Cycle. 2009;8(19):3149\u201356. https:\/\/doi.org\/10.4161\/cc.8.19.9698.","journal-title":"Cell Cycle"},{"issue":"3","key":"9922_CR125","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/pros.20262","volume":"64","author":"A Stangelberger","year":"2005","unstructured":"Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin\/gastrin releasing peptide (BN\/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF\/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. Prostate. 2005;64(3):303\u201315. https:\/\/doi.org\/10.1002\/pros.20262.","journal-title":"Prostate"},{"issue":"1","key":"9922_CR126","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2009.12.014","volume":"293","author":"S Bellyei","year":"2010","unstructured":"Bellyei S, Schally AV, Zarandi M, Varga JL, Vidaurre I, Pozsgai E. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro. Cancer Lett. 2010;293(1):31\u201340. https:\/\/doi.org\/10.1016\/j.canlet.2009.12.014.","journal-title":"Cancer Lett"},{"issue":"4","key":"9922_CR127","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ijc.20437","volume":"112","author":"CA Kanashiro","year":"2004","unstructured":"Kanashiro CA, Schally AV, Zarandi M, Hammann BD, Varga JL. Suppression of growth of H-69 small cell lung carcinoma by antagonists of growth hormone releasing hormone and bombesin is associated with an inhibition of protein kinase C signaling. Int J Cancer. 2004;112(4):570\u20136. https:\/\/doi.org\/10.1002\/ijc.20437.","journal-title":"Int J Cancer"},{"key":"9922_CR128","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7827-8-54","volume":"8","author":"J Guo","year":"2010","unstructured":"Guo J, Schally AV, Zarandi M, Varga J, Leung PC. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway. Reprod Biol Endocrinol. 2010;8:54. https:\/\/doi.org\/10.1186\/1477-7827-8-54.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"9922_CR129","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1073\/pnas.1620884114","volume":"114","author":"P Popovics","year":"2017","unstructured":"Popovics P, Schally AV, Salgueiro L, Kovacs K, Rick FG. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells. Proc Natl Acad Sci USA. 2017;114(6):1359\u201364. https:\/\/doi.org\/10.1073\/pnas.1620884114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9922_CR130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MOU.0b013e32835abd18","volume":"23","author":"FG Rick","year":"2013","unstructured":"Rick FG, Saadat SH, Szalontay L, Block NL, Kazzazi A, Djavan B, Schally AV. Hormonal manipulation of benign prostatic hyperplasia. Curr Opin Urol. 2013;23(1):17\u201324. https:\/\/doi.org\/10.1097\/MOU.0b013e32835abd18.","journal-title":"Curr Opin Urol"},{"issue":"8","key":"9922_CR131","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/pros.22633","volume":"73","author":"FG Rick","year":"2013","unstructured":"Rick FG, Schally AV, Block NL, Abi-Chaker A, Krishan A, Szalontay L. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia. Prostate. 2013;73(8):873\u201383. https:\/\/doi.org\/10.1002\/pros.22633.","journal-title":"Prostate"},{"issue":"51","key":"9922_CR132","doi-asserted-by":"publisher","first-page":"20470","DOI":"10.1073\/pnas.0811209106","volume":"105","author":"N Barabutis","year":"2008","unstructured":"Barabutis N, Schally AV. Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line. Proc Natl Acad Sci U S A. 2008;105(51):20470\u20135. https:\/\/doi.org\/10.1073\/pnas.0811209106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9922_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260144","volume":"17","author":"B Ayhan-Sahin","year":"2022","unstructured":"Ayhan-Sahin B, Apayd\u0131n ZE, Obakan-Yerlikaya P, Arisan ED, Coker-Gurkan A. Synthesis and characterization of novel ssDNA X-aptamers targeting Growth Hormone Releasing Hormone (GHRH). PLoS ONE. 2022;17(1): e0260144. https:\/\/doi.org\/10.1371\/journal.pone.0260144.","journal-title":"PLoS ONE"},{"key":"9922_CR134","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c00577","author":"MT Matsoukas","year":"2024","unstructured":"Matsoukas MT, Radomsky T, Panagiotopoulos V, Preez RD, Papadourakis M, Tsianakas K, Millar RP, Anderson RC, Spyroulias GA, Newton CL. Identification of small-molecule antagonists targeting the growth hormone releasing hormone receptor (GHRHR). J Chem Inf Model. 2024. https:\/\/doi.org\/10.1021\/acs.jcim.4c00577.","journal-title":"J Chem Inf Model"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09922-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-024-09922-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09922-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:24:35Z","timestamp":1749011075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-024-09922-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9922"],"URL":"https:\/\/doi.org\/10.1007\/s11154-024-09922-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"type":"print","value":"1389-9155"},{"type":"electronic","value":"1573-2606"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"24 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}